Montelukast Oral Granules Unicorn 4.15 mg Oral granules.
PDF Leaflet Revision Date: 20 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma in children 2 to 5 years.
Dosage (summary)
One sachet (4 mg) daily in the evening for children 2-5 years.
Onset of Action / Duration
Onset: 1 day, Duration: Not specified
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Caution with CYP inducers (e.g., phenytoin, phenobarbital)
Contraindications
- Known sensitivity to montelukast
- Children under 2 years
Common side effects
- Upper respiratory infection
- Headache
- Diarrhoea
- Rash
Counselling Points
- Take daily as prescribed, even if asymptomatic.
- Have rescue medication available for acute attacks.
- Report any changes in behavior or mood.
Serious warnings
- Not for acute asthma attacks
- Monitor for neuropsychiatric events
Important Disclaimer
The Montelukast Oral Granules Unicorn 4.15 mg Oral granules. professional information leaflet below is the property of Sandoz Sa 1 and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
